Mohammad S. Rostami

Array ( [id] => 1316045 [patent_doc_number] => 06608044 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-19 [patent_title] => 'Inhibition of TNF activity' [patent_app_type] => B1 [patent_app_number] => 09/623225 [patent_app_country] => US [patent_app_date] => 2000-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 8647 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/608/06608044.pdf [firstpage_image] =>[orig_patent_app_number] => 09623225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093191 [patent_doc_number] => 06825206 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-30 [patent_title] => 'Camptothecin compounds with a thioether group' [patent_app_type] => B1 [patent_app_number] => 09/712912 [patent_app_country] => US [patent_app_date] => 2000-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 9152 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 630 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825206.pdf [firstpage_image] =>[orig_patent_app_number] => 09712912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4371635 [patent_doc_number] => 06288108 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Methods for increasing levels of acetylcholine' [patent_app_type] => 1 [patent_app_number] => 9/700505 [patent_app_country] => US [patent_app_date] => 2000-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3480 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288108.pdf [firstpage_image] =>[orig_patent_app_number] => 700505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1425599 [patent_doc_number] => 06503920 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Cabergoline and pramipexole: new uses and combinations' [patent_app_type] => B1 [patent_app_number] => 09/674838 [patent_app_country] => US [patent_app_date] => 2000-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3738 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503920.pdf [firstpage_image] =>[orig_patent_app_number] => 09674838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7623701 [patent_doc_number] => 06686464 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-03 [patent_title] => 'Cellulose ethers and method of preparing the same' [patent_app_type] => B1 [patent_app_number] => 09/704258 [patent_app_country] => US [patent_app_date] => 2000-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11446 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686464.pdf [firstpage_image] =>[orig_patent_app_number] => 09704258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391761 [patent_doc_number] => 06548662 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Method for purification of saccharide' [patent_app_type] => B1 [patent_app_number] => 09/693373 [patent_app_country] => US [patent_app_date] => 2000-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4411 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548662.pdf [firstpage_image] =>[orig_patent_app_number] => 09693373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 985573 [patent_doc_number] => 06924301 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-02 [patent_title] => 'Composition for treating or preventing arrhythmia' [patent_app_type] => utility [patent_app_number] => 10/111090 [patent_app_country] => US [patent_app_date] => 2000-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12469 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924301.pdf [firstpage_image] =>[orig_patent_app_number] => 10111090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1290489 [patent_doc_number] => 06632940 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Method for laminaribiose synthesis' [patent_app_type] => B1 [patent_app_number] => 09/673295 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5547 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632940.pdf [firstpage_image] =>[orig_patent_app_number] => 09673295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014684 [patent_doc_number] => 06894026 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-17 [patent_title] => 'Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders' [patent_app_type] => utility [patent_app_number] => 09/678591 [patent_app_country] => US [patent_app_date] => 2000-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15474 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/894/06894026.pdf [firstpage_image] =>[orig_patent_app_number] => 09678591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1566920 [patent_doc_number] => 06376516 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Noscapine and noscapine derivatives, useful as anticancer agents' [patent_app_type] => B1 [patent_app_number] => 09/582375 [patent_app_country] => US [patent_app_date] => 2000-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7441 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376516.pdf [firstpage_image] =>[orig_patent_app_number] => 09582375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494728 [patent_doc_number] => 06342531 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment' [patent_app_type] => B1 [patent_app_number] => 09/646529 [patent_app_country] => US [patent_app_date] => 2000-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3356 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342531.pdf [firstpage_image] =>[orig_patent_app_number] => 09646529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1401747 [patent_doc_number] => 06538023 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Therapeutic uses of green tea polyphenols for sickle cell disease' [patent_app_type] => B1 [patent_app_number] => 09/663455 [patent_app_country] => US [patent_app_date] => 2000-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2392 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/538/06538023.pdf [firstpage_image] =>[orig_patent_app_number] => 09663455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1153041 [patent_doc_number] => 06767899 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-27 [patent_title] => 'Composition and method for treatment of conditions having an inflammatory component' [patent_app_type] => B1 [patent_app_number] => 09/650055 [patent_app_country] => US [patent_app_date] => 2000-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 8598 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/767/06767899.pdf [firstpage_image] =>[orig_patent_app_number] => 09650055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1246027 [patent_doc_number] => 06677356 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Treatment of cardiovascular and related pathologies' [patent_app_type] => B1 [patent_app_number] => 09/645237 [patent_app_country] => US [patent_app_date] => 2000-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 9914 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677356.pdf [firstpage_image] =>[orig_patent_app_number] => 09645237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514907 [patent_doc_number] => 06420410 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Method for treating neoplasia by exposure to N,N-substituted benzimidazol-2-ones' [patent_app_type] => B1 [patent_app_number] => 09/639909 [patent_app_country] => US [patent_app_date] => 2000-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12604 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 316 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420410.pdf [firstpage_image] =>[orig_patent_app_number] => 09639909 [rel_patent_id] =>[rel_patent_doc_number] =>)